Bayer poaches newest early R&D head from Roche; GlaxoSmithKline earns expanded nod for Shingrix
Bayer has plucked its new head of research and early development from Roche’s pRED organization, where he was doing much the same thing before making …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
